NCT07075666Enrolling by invitation
Early Detection of Prostate Cancer of Syrian Men
Early Detection of Prostate Cancer Among Men in the Middle Region of Syria
Source: ClinicalTrials.gov · Last updated 20 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Prostate cancer is a significant health concern in the Middle East, including Syria, where many cases are diagnosed at advanced stages due to low awareness and inadequate screening practices. The mortality-to-incidence ratio for prostate cancer in the region is alarmingly high, indicating a pressing need for effective early detection strategies.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 11 Jul 2025
- Start date
- 17 May 2025
- Primary completion date
- 31 May 2025
- Lead sponsor
- Al-Hawash Private University
- Diseases
- Prostate cancer
- NCT number
- NCT07075666
What you commit to
- Study type: Observational
- Planned participants: 1000
- From 17 May 2025 to the primary completion date, 31 May 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Men with a previous diagnosis of prostate cancer.
Who the study is looking for
- Men aged 40 years and older residing in the middle region of Syria.
Age in the registry: 40 years to 65 years · Sex: Male
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Al-Hawash Private University Coordinator of this site? Confirm its status | Homs | Syria | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.